Abnova produce y desarrolla mas de 19.000 proteínas recombinantes, mas de 12.000 anticuerpos MaxPab, mas de 16.000 anticuerpos monoclonales y mas de 20.000 anticuerpos policlonales dirigidos al genoma humano.
CD11 VHH recombinant monoclonal antibody
CD14 VHH recombinant monoclonal antibody
CD154 VHH recombinant monoclonal antibody
CD163 VHH recombinant monoclonal antibody
CD166 VHH recombinant monoclonal antibody
CD16a VHH recombinant monoclonal antibody
CD18 VHH recombinant monoclonal antibody
CD20 VHH recombinant monoclonal antibody
CD200 VHH recombinant monoclonal antibody
CD27 VHH recombinant monoclonal antibody
CD28 VHH recombinant monoclonal antibody
CD3 VHH recombinant monoclonal antibody